Other Vaccines - Lebanon

Lebanon

Highlights

Lebanon's Other Vaccines market is anticipated to achieve a revenue of US$12.33m in 2024.
It is projected to exhibit a Compound Annual Growth Rate (CAGR) of 9.16% from 2024 to 2029, leading to a market volume of US$19.11m by 2029.
When compared globally, United States is expected to generate the highest revenue, reaching US$24.73bn in 2024.
Lebanon's demand for other vaccines remains high due to the country's commitment to public health and strong vaccination infrastructure.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Amidst the growing demand for vaccines, the Other Vaccines market in Lebanon has been witnessing significant growth in recent years.

Customer preferences: Lebanon has a high demand for vaccines due to its population's awareness of the importance of vaccination. The majority of the population prefers to get vaccinated to protect themselves from various diseases. The government also encourages vaccination programs to ensure public health.

Trends in the market: The Other Vaccines market in Lebanon has been growing due to the introduction of new vaccines and the increasing demand for existing vaccines. The market has been witnessing significant growth in the past few years, and this trend is expected to continue in the coming years. The increasing prevalence of infectious diseases, coupled with the rising awareness of the importance of vaccination, is driving the growth of the market.

Local special circumstances: Lebanon has been facing a significant economic crisis in recent years, which has affected the healthcare sector. The country has been struggling with a shortage of medical supplies and equipment, including vaccines. However, the government has been taking steps to address these issues and ensure that the population has access to vaccines.

Underlying macroeconomic factors: Lebanon's economy has been facing several challenges, including political instability, inflation, and a high debt-to-GDP ratio. These factors have affected the healthcare sector, including the vaccine market. However, the government has been taking measures to address these issues and improve the healthcare system. The introduction of new vaccines and the increasing demand for existing vaccines are expected to drive the growth of the Other Vaccines market in Lebanon in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.